Oramed Pharmaceuticals has been focused on protecting inventions in Denmark(DK) with one publication in Q2 2024
The Denmark(DK) Patent Office dominates the patent filings with nearly 50% of filings. The Denmark(DK), United States(US), and European Patent Office(EPO) patent Office are among the top ten patent offices where Oramed Pharmaceuticals is filings its patents. Among the top granted patent authorities, Oramed Pharmaceuticals has 100% of its grants in European Patent Office(EPO).
Patents related to rare diseases lead Oramed Pharmaceuticals’s portfolio
Oramed Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
Fatty liver disease related patents lead Oramed Pharmaceuticals portfolio followed by non alcoholic fatty liver disease (nafld), and non-alcoholic steatohepatitis (nash)
Oramed Pharmaceuticals has highest number of patents in fatty liver disease followed by non alcoholic fatty liver disease (nafld), non-alcoholic steatohepatitis (nash).
For comprehensive analysis of Oramed Pharmaceuticals‘s filings and grants, buy the databook here.
From 
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.